The leprosy problem - Back to the dermatologists

Leprosy Review

Volumn 78, Issue 1, 2007, Pages 22-25

  Porchha, D ^a  

^a L 3/110 ^*  (India)

Author keywords

[No Author keywords available]

Indexed keywords

DAPSONE; MINOCYCLINE; OFLOXACIN; RIFAMPICIN;

BACTERIAL TRANSMISSION; CLINICAL FEATURE; DERMATOLOGY; HEALTH PROGRAM; HUMAN; LEPROSY; PLASTIC SURGERY; PUBLIC HEALTH; REVIEW; SOCIAL WORKER; SYSTEM ANALYSIS; WORLD HEALTH ORGANIZATION;

COMMUNICABLE DISEASE CONTROL; DERMATOLOGY; DRUG RESISTANCE, BACTERIAL; HUMANS; LEPROSY;

EID: 34547105576     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Noordeen SK. Leprosy control, elimination and eradication. Ind J Lepr, 2000; 72: 65-68.
2. Cochrane RG, Ramanujam K, Paul H, Russel D. Two and half years experimental work on the sulphone group of drugs. Lepr Rev, 1949; 20: 4-64.
3. 3WHO study group: Chemotherapy of leprosy for control programmes. WHO TRS, No. 675, WHO Geneva, 1982.
4. Noordeen SK. The debate over leprosy elimination versus sustainability of leprosy services. Editorial. Ind J Lepr, 2005; 77: 299-304.
5. Dapasquale G. Rifampicin and isoprodion in combination in the treatment of leprosy. Lepr Rev (suppl), 1975; 57: 179-180.
6. WHO. Programme strategy for further reducing the leprosy burden and sustaining leprosy control activities. 2006, Document No WHO/CDS/CPE/CEE/2005. 53.
7. Braber KL. An evaluation of GALE - the Global Alliance for Leprosy Elimination. Lepr Rev, 2004; 75: 208-213.
8. Waters MFR. Is it safe to shorten multidrug therapy for lepromatous (LL, BL) leprosy to 12 months? Lepr Rev, 1998; 69: 110-111.
9. Desikan KV. The risk of relapse after multidrug therapy in leprosy. Editorial. Lepr Rev, 1997; 68: 114-116.
10. WHO. Remaining challenges towards the elimination of leprosy. Ind J Lepr, 2000; 72: 35-45.
11. Ebenezer GJ, Norman G, Joseph GA et al. Drug resistant Mycobacterium leprae. Result of mouse foot pad studies from laboratory in South India. Ind J Lepr, 2002; 74: 301-312.
12. Jamet P, Ji Baohony. The Marchoux Chemotherapy study group. Relapse after long-term follow up of MB cases treated by WHO multidrug regimen. Int J Lepr Other Mycobact Dis, 1995; 63: 195-201.
13. Williams DL, Gills PT. Molecular detection of drug resistance in Mycobacterium leprae. Lepr Rev, 2004; 75: 118-130.
14. Girdhar BK. Multidrug therapy in leprosy and its future components. Ind J Lepr, 1994; 66: 179-208.
15. Gupte MD, Manickam MD (eds) Report on National Workshop on Surveillance of Leprosy. Chennai, 2005.
16. National Leprosy Eradication Programme-Disability Prevention and Medical Rehabilitation (DPMR)-Implementation plan, Issued by Leprosy Division, DGHS, New Delhi. 2006.